Investing.com -- Danish drugmaker Novo Nordisk (NYSE: NVO) announced Tuesday that Canada’s health regulator has approved its diabetes drug Ozempic for additional uses related to kidney disease.

Investing.com -- Global macro hedge funds and long-only funds have stepped in to support equities just as retail demand has ...

Investing.com -- Phoenix Mecano (SIX: PMN) shares fell over 3% on Tuesday after the Swiss manufacturer reported a sharp drop in second-quarter profit, weighed by weaker demand and restructuring costs.

Investing.com -- Howden has named Chris Hughes as the new chief executive of its New Zealand broking business, with the appointment set to take effect in November. Hughes will report directly to Matt ...

Investing.com -- Nvidia (NASDAQ: NVDA) has overtaken its peers as the most under-owned mega-cap technology stock, according ...

Investing.com -- Viking Therapeutics (NASDAQ: VKTX) stock fell 21% Tuesday morning despite announcing positive Phase 2 trial results for its oral obesity drug that showed significant weight loss in ...

Investing.com -- Commodity trading advisors (CTAs) are near their maximum equity exposure, leaving little room for further buying, according to UBS. “CTAs are close to max long in equities, and are ...

Toronto Stock Exchange’s S&P/TSX composite index closed Monday 0.1%, or 17 points, higher at 27,922.85. The meeting to ...

At Jefferies’ revised price target, the stock would trade about 21% higher. The brokerage cited Nemluvio’s launch momentum and improved profitability as key drivers of further upside, despite softness ...

Nvidia (NASDAQ: NVDA) continues to be the largest AI beneficiary, while Micron (NASDAQ: MU ), Applied Materials (NASDAQ: AMAT ), and KLA Corp also delivered strong results with positive sentiment.

The European Central Bank (ECB) easing cycle could end soon, which has helped bring down volatility of some money market ...

Investing.com -- The South African rand is expected to gain the most among emerging market currencies as the U.S. dollar ...